ApprovalTrail

Natural health product · NPN 80145728

MitoForte

Yes: licensed in Canada

The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.

Licence status Active; licensed November 27, 2025; licence last revised June 10, 2026.
Natural Product Number (NPN)
80145728
Dosage form
Capsule
Route
Oral
Licensing route
General (non-traditional)
First licensed
November 27, 2025
Licence last revised
June 10, 2026

Also sold as

Other product names on the same licence.

  • Mito Fortification
  • Mito Fortify
  • Mito Plus
  • Mito+

Medicinal ingredients

Per dosage unit, as licensed.

IngredientAmount
3-(Aminocarbonyl)-1-(5-O-phosphonato-beta-D-ribofuranosyl)pyridinium75 mg
Vitamin B12100 micrograms
Riboflavin5 mg
1,2-Dithiolane-3-pentanoic acid, (R)50 mg
Thiamine10 mg
2-Biphenylcarboxylic acid, 2',4,4'-trihydroxy-, delta-lactone250 mg
Vitamin B65 mg
2,5-Cyclohexadiene-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl50 mg
1H-Pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylic acid, 4,5-dihydro-4,5-dioxo-10 mg

What it is licensed for

The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.

  • A factor in normal growth and development. Helps (to) maintain/support the body's ability to metabolize nutrients. Helps in energy metabolism/(and) tissue formation. NMN is a NAD+ precursor which helps to support biological functions which play a key role in the maintenance of good health. NMN is a NAD+ precursor which is an important cofactor in energy metabolism. Source of (an) antioxidant(s)/Provides (an) antioxidant(s). Helps to support mitochondrial function by protecting against oxidative stress-induced damage.

Non-medicinal ingredients

Silicon dioxide; Microcrystalline cellulose; Ascorbyl palmitate; Hypromellose